prophylactic or therapeutic composition for haemoglobinuria or myoglobinuria which may lead

• 1. 用于治疗阵发性夜间血红蛋白尿的抑制MASP-1、MASP-2和/或MASP-3的组合物和方法 [P] . 中国专利： CN104661676A . 2015-05-27
• 2. 治疗由阴道加德纳氏菌导致的细菌性阴道感染和可能存在的并发真菌感染的乳酸菌组合物 [P] . 中国专利： CN109475584A . 2019-03-15
• 3. PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR HEMOGLOBINURIA OR MYOGLOBINURIA [P] . 欧洲知识产权局专利： EP1913943B1 . 2011-09-21

  机译： 血红蛋白尿或肌红蛋白尿的益生或治疗组合物

• 4. PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR HEMOGLOBINURIA OR MYOGLOBINURIA [P] . 美国专利： US2011251153A1 . 2011-10-13

  机译： 血红蛋白尿或肌红蛋白尿的益生或治疗组合物

• 5. PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR HEMOGLOBINURIA OR MYOGLOBINURIA [P] . 美国专利： US2009306208A1 . 2009-12-10

  机译： 血红蛋白尿或肌红蛋白尿的益生或治疗组合物

• 1. Lead Isotopic Composition and Lead Source in the Bainiuchang Ag-polymetallic Deposit, Yunnan Province, China [J] . ZHU Chaohui, ZHANG Qian, SHAO Shuxun, 地质学报（英文版） . 2008,第004期
• 2. Lead Isotopic Composition and Lead Source in the Bainiuchang Ag-polymetallic Deposit, Yunnan Province, China [J] . ZHU Chaohui, ZHANG Qian, SHAO Shuxun, 地质学报：英文版 . 2008,第004期
• 3. Lead Isotopic Composition and Lead Source of the Huogeqi Cu-Pb-Zn Deposit, Inner Mongolia, China [J] . ZHU Xiaoqing, ZHANG Qian, HE Yuliang, 地质学报（英文版） . 2006,第004期
• 4. Primary Myoglobinuria: Differentiate Myoglobinuria from Hemoglobinuria [J] . Dhiraj J. Trivedi, Shrirang P. Kulkarni, Rakesh Mudaraddi Indian journal of clinical biochemistry . 2017,第3期
• 5. Primary Myoglobinuria: Differentiate Myoglobinuria from Hemoglobinuria [J] . Dhiraj J. Trivedi, Shrirang P. Kulkarni, Rakesh Mudaraddi Indian journal of clinical biochemistry . 2017,第3期
• 6. Primary Myoglobinuria: Differentiate Myoglobinuria from Hemoglobinuria [J] . Dhiraj J. Trivedi, Shrirang P. Kulkarni, Rakesh Mudaraddi Indian journal of clinical biochemistry . 2017,第3期
• 7. Chimpanzee ad vector technology platform for prophylactic and therapeutic genetic vaccine applications [C] . Stefano Colloca Vaccine technology IV . 2012
• 8. I. ANCIENT ARCTIC ICE DOES NOT CONTAIN LARGE EXCESSES OF NATURAL LEAD. II. CHRONOLOGICAL VARIATIONS IN LEAD AND BARIUM CONCENTRATIONS AND LEAD ISOTOPIC COMPOSITIONS IN SEDIMENTS OF FOUR SOUTHERN CALIFORNIA OFF-SHORE BASINS. [D] . NG, CHIHANG AMY. 1982
• 9. Primary Myoglobinuria: Differentiate Myoglobinuria from Hemoglobinuria [O] . Dhiraj J. Trivedi, Shrirang P. Kulkarni, Rakesh Mudaraddi 2017
• 10. Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression [O] . J. Ballarin, Y. Arce, R. Torra Balcells, 2011
• 11. Chemical Data and Lead Isotopic Compositions of Geochemical Baseline Samples fromStreambed Sediments and Smelter Slag, Lead Isotopic Compositions in Fluvial Tailings, and Dendrochronology Results from the Boulder River Watershed, Jefferson County, Montana [R] . Unruh, D. M., Fey, D. L., Church, S. E. 2000

• 1. A Comparative Investigation of Lead Sulfate and Lead Oxide Sulfate Study of Morphology and Thermal Decomposition [J] . S. A. A. Sajadi . 美国分析化学（英文） . 2011,第2期
• 2. Influence of TiO_2 seeding layers on phase composition of lead magnesium niobate-lead titanate thin films prepared by RF magnetron sputtering [J] . WANG JunmingLI Weiliand FEI Weidong School of Materials Science EngineeringHarbin Institute of TechnologyHarbin 150001China . 稀有金属：英文版 . 2007,第S1期
• 3. 高原地区足月新生儿窒息后血肌红蛋白、尿a1微球蛋白、尿肌红蛋白的变化与肾功能损害 [C] . 刘充德 . 中华医学会第十八次全国儿科学术会议 . 2013
• 4. 化疗联合粒细胞集落刺激因子(DAG)治疗阵发性睡眠性血红蛋白尿症疗效及其机制的探索 [A] . 董喜凤 . 2013